Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.976
-0.054 (-5.24%)
At close: Nov 20, 2024, 4:00 PM
0.980
+0.004 (0.42%)
Pre-market: Nov 21, 2024, 7:01 AM EST
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of $20.89 million as of November 21, 2024. Its market cap has decreased by -46.43% in one year.
Market Cap
20.89M
Enterprise Value
-4.21M
1-Year Change
-46.43%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since July 31, 2014, Enlivex Therapeutics's market cap has decreased from $92.70M to $20.89M, a decrease of -77.46%. That is a compound annual growth rate of -13.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 21.50M | -57.17% |
| Dec 29, 2023 | 50.20M | -30.76% |
| Dec 30, 2022 | 72.50M | -36.74% |
| Dec 31, 2021 | 114.60M | 31.57% |
| Dec 31, 2020 | 87.10M | 2,388.57% |
| Dec 31, 2019 | 3.50M | 34.62% |
| Dec 31, 2018 | 2.60M | -65.33% |
| Dec 29, 2017 | 7.50M | -49.32% |
| Dec 30, 2016 | 14.80M | -73.14% |
| Dec 31, 2015 | 55.10M | -33.69% |
| Dec 31, 2014 | 83.10M | -10.36% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spectral AI | 21.45M |
| GlycoMimetics | 21.28M |
| Pieris Pharmaceuticals | 21.20M |
| Cocrystal Pharma | 20.96M |
| MIRA Pharmaceuticals | 20.95M |
| NeuroBo Pharmaceuticals | 20.68M |
| Pulmatrix | 20.53M |
| BriaCell Therapeutics | 20.52M |